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The applications of Western/immunoblotting (WB)
techniques have reached multiple layers of the scientific
community and are now considered routine procedures in
the field of physiology. This is none more so than in
relation to skeletal muscle physiology (i.e., resolving the
mechanisms underpinning adaptations to exercise). Indeed,
the inclusion of WB data is now considered an essential
aspect of many such physiological publications to provide
mechanistic insight into regulatory processes. Despite
this popularity, and due to the ubiquitous and relatively
inexpensive availability of WB equipment, the quality of
WB in publications and subsequent analysis and
interpretation of the data can be variable, perhaps
resulting in spurious conclusions. This may be due to poor
laboratory technique and/or lack of comprehension of the
critical steps involved in WB and what quality control
procedures should be in place to ensure robust data
generation. The present review aims to provide a detailed
description and critique of WB procedures and
technicalities, from sample collection through preparation,
blotting and detection, to analysis of the data collected.
We aim to provide the reader with improved expertise to
critically conduct, evaluate, and troubleshoot the WB
process, to produce reproducible and reliable blots.
The Western blot (WB) has diverse applications for
investigating regulatory molecular events underpin-
ning energy metabolism, protein turnover and
chronic physiological adaptations. For example, the
WB can be used to investigate protein abundance,
kinase activity, cellular localization, protein–protein
interactions, or monitoring of post-translational
modifications [i.e., events of cleavage, phosphoryla-
tion (Nairn et al., 1982), ubiquitinylation (Paul
et al., 2012), glycosylation (Pere-Brissaud et al.,
2015), methylation (Voelkel et al., 2013), and
SUMOylation (Park-Sarge & Sarge, 2010); to name
the main applications]. While such WB approaches
are routinely used in many fields of biochemical
research, the application of the WB to skeletal mus-
cle and exercise physiology is increasing. This is for
reasons relating to the pursuit of an improved under-
standing of molecular pathways involved in the regu-
lation of transcription and translation by exercise
and nutrition in health, aging, and disease. This
expansion in WB applications has led to an increased
number of users lacking analytical biochemistry
backgrounds to appreciate important caveats.
Crucial quality control elements of a WB may be
overlooked, leading to poor quality blots, and the
potential for unintentionally misleading data pro-
duction and interpretation.
Outwardly, the principle of the WB is based
around a few broad steps: (a) the extraction of cellu-
lar proteins from a complex mixture of intracellular
and extracellular proteins (from tissue, cells, etc.); (b)
quantification of protein concentration and elec-
trophoretic separation of proteins within a gel
matrix; (c) transfer to a membrane with a high affin-
ity for proteins; (d) “blocking” the membrane to
reduce non-specific binding; (e) antigen detection by
antibodies specific for the protein(s) of interest; (f)
incubation with a secondary antibody linked to a
label (e.g., chemiluminescent or fluorescent); (g)
development and detection of the signal, which is
theoretically proportional to the degree of antigen/
antibody binding; and (h) quantification of the
resulting bands using densitometry software (Fig. 1).
Originally, the process of “Western blotting” was the
aspect of transferring proteins from a gel to a more
stable membrane, although it commonly now refers
to the whole process. To allow for the greatest accu-
racy and interpretation of data, each aspect of the
WB process must be understood and carefully con-
sidered. In this review, we will describe the stages of
the WB, focusing on the more routine WB gel
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electrophoresis methodologies using standard SDS-
PAGE, wet transfers, and chemiluminescence, cri-
tiquing and highlighting important points to
consider throughout. In the main, we will
concentrate on analysis of skeletal muscle tissues
derived from skeletal muscle biopsies; nonetheless,
the details described in each element are inherently
applicable to other tissues or sample types. While
performing a WB, there are multiple key aspects to
each step:
Sample preparation:
• Is the target protein soluble/cytoplasmic, insoluble
or membrane bound?
• Are additional buffer components (e.g., deter-
gents, enzymatic inhibitors) required for solubi-
lization, fractionation, or maintenance of post-
translational modifications?
• What is the method of protein quantification, will
buffer components interfere?
Polyacrylamide gel electrophoresis:
• What concentration of gel is most appropriate
(e.g., 20% for proteins <20 kDa, 7.5% for pro-
teins >200 kDa)?
• What running buffer is most suitable (e.g., MOPS
for proteins ~75 kDa, MES for proteins <36 kDa)?
Fig. 1. The sequential stages of the Western blot process.
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• How long and what voltage to run the tank (typi-
cally 60 min at 200 V)?
Electro-transfer:
• What is the most suitable membrane material
(e.g., PVDF or nitrocellulose) and pore size (e.g.,
0.45 lm)?
• Is methanol excluded in the buffer (i.e., for trans-
fer of larger proteins)?
• Should membrane staining occur to assess transfer
efficiency (e.g., Ponceau)?
Blocking:
• Which blocking reagent is most suitable (e.g., BSA
or milk)?
• What concentration (e.g., 2.5%) and what buffer
(e.g., TBST) should be used?
Primary antibody:
• What are the general characteristics of the primary
antibody (e.g., monoclonal Rabbit IgG)?
• Is it specific toward native or denatured proteins
and is the epitope sequence/region know?
• Are additional bands known/present (i.e., degra-
dation products or protein isoforms)?
• Have appropriate controls been run to determine
specificity?
• Is the antibody specific to a post-translational
modification (e.g., phosphorylation)?
Secondary antibody:
• What is the label conjugation (e.g., HRP or fluo-
rescent)?
• Is the secondary antibody specific toward the pri-
mary isotype?
• Is there detectable/overexposed signal, if so is an
antibody dilution curve required?
Detection:
• What is the detection method (e.g., chemilumines-
cent or fluorescent)?
• Is fluorescent multiplexing suitable?
• Have the antibodies been stored correctly?
• Can the membrane be successfully stripped and
reprobed?
Analysis and normalization:
• Is the band of interest within the linear range of
the detection system?
• What method of quantification is most suitable
(i.e., whole lane or boxed analysis)?
• What is the method of background detection (e.g.,
rolling ball algorithm)?
• What is the method of normalization (e.g., Coo-
massie stain)?
• Is it more suitable to measure the total vs phos-
phorylation expression of a protein?
Sample handling
The method of sample collection depends on the
sample type: skeletal muscle tissue by biopsy [i.e., for
human tissue typically by conchotome or Bergstr€om
needle (Dietrichson et al., 1987)], samples dissected
post-mortem (i.e., after the terminal procedure of an
in vivo experiment), and cell culture using scrapers
(Quach et al., 2009). Once tissue samples are har-
vested, they should be immediately washed in an ice-
cold neutral pH buffer, before removal of visible fat,
snap frozen in liquid N2, and stored at 80 °C.
These steps are designed to limit protein degradation
and preserve post-translational modifications
(PTMs), while concurrently reducing non-skeletal
muscle cell contaminants and blood, all of which
could interfere with downstream processes (e.g.,
hemoglobin may interfere with colorimetric protein
assays (Doumas et al., 1981) or contaminate muscle
cell-specific analysis). In order to obtain robust data,
samples should remain frozen until use and undergo
as little manipulation as possible (e.g., periods at
higher temperatures and multiple freeze thaws, so to
minimize degradation as indicated by gel streaks)
(Mahmood & Yang, 2012). Sometimes, it may be
viable for fresh tissue to be utilized for WB sample
preparation; however, it is more common and in our
experience preferable to snap freeze tissues. This
allows multiple analyses to be performed on a single
sample (e.g., mass spectrometry, quantitative real-
time PCR) while controlling the amount of tissue uti-
lized. Although typically whole skeletal muscle tissue
is used, it is possible to isolate and group fibers [i.e.,
based on fiber type (Jensen & Richter, 2011)] or use
individual fibers for WB analysis (Murphy & Lamb,
2013). These techniques, however, are time consum-
ing and may reduce the protein yield, but may be
more informative depending on the experimental
design (i.e., influence of fiber type on an interven-
tion).
The extraction of proteins of interest from tissues
requires the lysis and disruption of cell membranes
using homogenization techniques, typically in the
form of mechanical, sonication, and/or chemical
approaches. For muscle biopsies or other solid tis-
sues, mechanical homogenization is required to
mince large sections of tissue and disrupt membranes
(in order to liberate intracellular proteins). High-
powered bench-top “polytron” homogenizers, com-
mercial “bead-beaters”, or simple scissor snipping
may be used to effectively release intracellular pro-
teins into solution (Goldberg, 2008). It is noteworthy
that certain mechanical methods (e.g., polytron
approaches) may retain remnants of tissues if not
thoroughly cleaned, leading to cross-sample contam-
ination. If protein yields are lower than expected
after quantification (e.g., in our experience yields for
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cultured cells are typically 0.5–1.5 lg/ll, human
skeletal muscle biopsies 3–6 lg/ll and excised rat
kidney 12–15 lg/ll) (discussed below), sonication of
samples might be required to further lyse cellular
membranes. Sonication utilizes high frequency sound
waves to disrupt cellular membranes, nonetheless,
this should follow mechanical homogenization to
remove large pieces of tissue that would not be dis-
rupted by sonication alone (Autuori et al., 1982).
Notably, homogenization of muscle cell cultures
does not require the same degree of mechanical lys-
ing; instead vigorously pipetting the collected cells
through a small gauge syringe or fine tip gel-loading
pipette is typically sufficient (Crossland et al., 2013).
Tissues should be homogenized in a buffer
designed to solubilize and optimize preservation of
the target proteins. Accurately buffering a homoge-
nization solution proximate to the isoelectric point
of proteins (the pH at which they have neutral
charge), is necessary (pH 7–9) to ensure solubility,
and prevention of protein precipitation, through
maintenance of positive or negatively charged amino
acid functional (R) groups (Grabski, 2009). Addition
of non-ionic detergents (i.e., Triton X-100) are used
to increase solubility of non-polar insoluble proteins
(Helenius & Simons, 1975). Proteins retaining ter-
tiary and quaternary structures remain soluble in
water, since non-polar hydrophobic regions are gen-
erally oriented toward the center of the protein or
within cell membranes (Tanford, 1962). Thus, reduc-
ing agents [e.g., dithiothreitol (DTT)] are used to
breakdown disulfide bonds (S-S) between cysteine
residues (Cleland, 1964), while sodium dodecyl sul-
fate (SDS) detergent is added to coat hydrophobic
regions of proteins with negative charge and over-
whelm positive charges in proteins; this aspect is cru-
cial for resolving proteins in accordance to their
molecular mass (discussed below). Reducing agents
are required in subsequent sample preparation stages
and may interfere with determining the protein con-
tent (discussed below), and thus it is recommended
where possible to avoid or minimize addition before
quantification.
The detection of certain proteins may require fur-
ther optimization of buffer components (typical inclu-
sions and concentrations in Table 1). For instance,
high concentrations of salts (i.e., NaCl) or detergents
to enhance breakdown of organelle and nuclear mem-
branes, such as radio-immunoprecipitation buffer to
ensure nuclear disruption (Holden & Horton, 2009).
An example of such necessary changes is for the
extraction of the DNA-bound proteins in muscle tis-
sue using hyperosmolar lysis buffers to effectively
release DNA-bound proteins, which can increase the
ability to detect low abundant proteins (Girgis et al.,
2014). Therefore, the cellular location and DNA bind-
ing of target protein(s) should be carefully considered
before determining optimal extraction buffers, which
could impact on quantification and therefore conclu-
sions being drawn.
Disruption of cell membranes during homogeniza-
tion also releases proteases, kinases, and phos-
phatases, and despite reduced storage temperatures
(i.e., 4 °C), protein degradation may still occur due
to retained enzymatic activity (Scopes, 1994). There-
fore, protease inhibitors that suppress the activity of
a variety of proteases must be added either individu-
ally or as a commercially dissolvable preparation
with the aim of preventing a broad a range of pro-
tease activities (e.g., aprotinin for serine and E-64 for
cysteine proteases) (Grabski, 2009). Metallopro-
teinases may be inhibited through the use of metal
chelators such as ethylenediaminetetraacetic acid
(EDTA) and ethylene glycol tetraacetic acid (EGTA)
via chelation (binding of metal ions) of Mg2+ and
Ca2+ which are required for protease activity (Auld,
1995). Further to this, EDTA and EGTA addition-
ally inhibit serine/threonine (Ser/Thr) phosphatase
interactions; however, some caution is warranted
since EDTA disrupts Na+ orthovanadate-mediated
inhibition of Tyr phosphatases (Huyer et al., 1997).
Other components are also required to maintain
Table 1. Common buffer components for use in tissue homogenization
Chemical Purpose Typical concentration
Triton x-100 Increase solubility of non-polar proteins 0.1–1%
Urea Disruption of protein hydrogen bonds increasing solubility 6–8 M
NaCl Membrane disruption and protein solubility 1–100 mM
SDS Membrane disruption 0.1–1%
Tris-HCl Solution buffering 50 mM
MOPS/MES Solution buffering 1–5 mM
HEPES Solution buffering 50 mM
Glycerol Solution stabilization 5–10%
EGTA/EDTA Inhibition of metalloproteases and prevention of changes in protein phosphorylation 1 mM
Na3VO4 Tyrosine and alkaline phosphatase inhibition 0.5 mM
NaF Ser/Thr phosphatase inhibition 50 mM
b-glycerophosphate Ser/Thr phosphatase inhibition 10 mM
b-mercaptoethanol Cleavage of disulfide bonds and protein denaturation 1–10 mM
DTT Cleavage of disulfide bonds and protein denaturation 1–10 mM
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protein phosphorylation states, changeable by phos-
phatases released by homogenization. As an example
of the importance of this step, the addition of phos-
phatase inhibitors was shown to result in increased
signal intensity for phosphorylated MAP kinase
within neuronal cells, whereas total-MAP kinase
intensity remained constant (Sharma & Carew,
2002). Interactions of tyrosine (Tyr) and alkaline
phosphatase are generally inhibited through the
addition of Na+ orthovanadate, acting as a competi-
tive Tyr phosphatase inhibitor (Gordon, 1991).
Additional inhibitors of Ser/Thr phosphatases such
as sodium fluoride and b–glycerophosphate may be
used in conjunction with these chelators, increasing
the effectiveness of the buffered solution to maintain
phosphorylated protein status. Typical buffer com-
ponents and concentrations can be found in Table 1.
It is important to note that any equipment or buffers
used within sample processing should be pre-chilled
and ideally kept cold on ice.
Cellular subfractionation and immunoprecipitation
Isolating specific cellular fractions (myofibrils, sar-
coplasm, mitochondria, collagen) is commonly per-
formed as part of the homogenization process for
multiple analysis (e.g., WB and mass spectrometry;
Wilkinson et al., 2008) as it may be of interest to
determine proteins with specific localizations (e.g.,
GLUT4 translocation across the plasma membrane;
Miura et al., 2001) or transcription factor DNA
binding (Girgis et al., 2014); however, successful iso-
lation may require additional buffer components
(discussed previously). For skeletal muscle, as a first
step, soluble proteins within the sarcoplasm are iso-
lated and separated from insoluble (in standard WB
buffers) myofibrillar fractions. The sarcoplasmic
fraction may be subject to further organelle separa-
tion through differential centrifugation and isolation
methods (utilizing fraction-specific buffers) into
mitochondrial and cytosolic fractions (Huff-Lone-
rgan et al., 1995; Dimauro et al., 2012). Commonly
mitochondrial isolation may involve the passing of
the homogenized sample through a Dounce homoge-
nizer as it preserves mitochondrial morphology, min-
imizing membrane disruption (Dounce et al., 1955).
Many of these isolation methods are relatively crude
in nature; therefore, steps need to be taken to assess
the purity and specificity of preparations (e.g., mea-
suring the presence or absence of fraction-specific
proteins). Most protocols require differential cen-
trifugation techniques (Huff-Lonergan et al., 1995;
Wilkinson et al., 2008), whereby insoluble myofibril-
lar fractions (containing mitochondria) are pelleted
by higher speed centrifugation (e.g., 11 000 g), with
remaining mitochondrial proteins isolated following
re-suspension, and a slower speed centrifugation
(e.g., 1000 g) before removal of the mitochondrial
containing supernatant. While crudely isolating
mitochondria, pure separation is difficult as skeletal
muscle mitochondria are integrated with structures
in the muscle (Rasmussen & Rasmussen, 2000). It
should also be noted that there are two main areas
within the muscle where mitochondria are associ-
ated: subsarcolemma and inter-myofibrillar (IM).
Robust separation of each fraction requires addi-
tional steps to mechanically or enzymatically (e.g.,
trypsinization) release IM mitochondria from the
myofibrils, which may in turn cause protein degrada-
tion to other structures or proteins within the
myofibrillar fraction (Rasmussen & Rasmussen,
2000). It is important to note the addition of trypsin
will require quenching typically through the addition
of albumin, increasing the total protein content in
subsequent quantification, and samples should,
therefore, be thoroughly washed (Beltran Valls et al.,
2014). A recent method has been described, which
involves short proteinase treatment and homogeniza-
tion in ionic buffers followed by two-stage centrifu-
gation. This method showed high mitochondrial
integrity and purity following isolation (Rasmussen
& Rasmussen, 2000). However, even with specific
isolation techniques, the chance of contamination or
protein degradation remains high. It is, therefore,
crucial to assess the relative purity for fractions isola-
tion by performing a WB for proteins known to be
associated with the desired location [e.g., GAPDH
and COXIV or cytochrome C for cytosolic and mito-
chondrial fractions, respectively (Dimauro et al.,
2012; Beltran Valls et al., 2014)]. Publications using
such techniques should be expected to provide good
evidence of fraction(s) purity.
Additional sample processing by immunoprecipi-
tation (IP) may be desirable before SDS-PAGE as it
allows the investigation of potential protein–protein
interactions (Crossland et al., 2013), and concentra-
tion of proteins of low abundance to be extracted for
accurate detection by subsequent blotting (Rascon
et al., 1992). Initially, the primary antibody (1°Ab)
specific to the desired protein is added to the homog-
enized lysate to form an immune complex that binds
to protein A or G beads (generally agarose), which
are centrifuged at low speed and the pelleted protein-
antibody complex bound beads removed. Proteins
may then be eluted and utilized for WB (Huang &
Kim, 2013). Through this, physically interacting pro-
teins will be captured by the target 1°Ab, allowing
their subsequent denaturation and separation by
SDS-PAGE. These interacting additional proteins
may then be blotted for, providing valuable insight
into potential protein–protein interactions as their
detection would only be possible if bound to the
originally IP-targeted protein. It is important to note
that the 1°Ab may also contaminate the sample as
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denatured heavy (50 kDa) and light chains (25 kDa)
will be present within the blot (Anton, 2008). If the
resulting blot contains either a strong background or
the band of interest is obscured by the denatured
chains, the use of label conjugated protein A or G
(e.g., Protein-A-HRP) may be used as they bind
almost exclusively to intact antibodies (i.e., the cho-
sen primary antibody) (Lal et al., 2005)
Protein quantification and gel loading
Following protein extraction, each sample requires
the standardization of total protein loading per well.
Quantification of protein content may be determined
through colorimetric (Bradford, 1976) or UV absor-
bance (280 nm) (Desjardins et al., 2009) methods.
The Bradford assay utilizes a colorimetric change of
Coomassie Brilliant Blue G-250 from 465 nm
(brown) unbound to 595 nm (blue) when bound to
protein (Bradford, 1976), with protein concentration
being proportional to the absorption at 595 nm with
reference to a standard curve of known concentra-
tions (typically 100–1500 lg/ml). This procedure is
simple to perform and requires only basic spec-
trophotometric equipment; furthermore the reaction
is rapid (~2 min) and the bound product is stable for
~1 h at room temperature (Bradford, 1976). A num-
ber of other methods based along similar biochemi-
cal colorimetric properties such as the Lowry,
bicinchoninic acid, and ortho-phthaladehyde assays
are also regularly reported for protein concentration
measures in WB procedures (Noble et al., 2007).
While popular, colorimetric assays have a number of
potential disadvantages in that they require more
sample than other modern methods (i.e., UV absor-
bance) and are susceptible to pipetting errors of
either the samples or during standard curve con-
struction, along with suffering from interference by a
number of buffer/tissue components [e.g., b-mercap-
toethanol (b-MCE)] or hemoglobin (Doumas et al.,
1981). Measuring protein content through UV
absorption with the use of micro-spectrophotometric
(e.g., Nanodrop) equipment may be more suitable
due to the comparatively small sample volume (0.5–
2 ll), wide quantification range (0.1–3000 lg at
280 nm), and potential for complete sample recovery
once the measurement is complete (Desjardins et al.,
2009). This procedure utilizes the absorbance of UV
light at 280 nm by amino acids containing aromatic
rings (i.e., phenylalanine, tyrosine, and tryptophan)
allowing accurate quantification (Layne, 1957).
Erroneous measurements may occur if the sample
comprises both insoluble and soluble proteins that
will affect absorbance measurements, demonstrating
the importance of sample homogeneity. Moreover,
to ensure reproducibility, standard curves of known
protein concentrations should be performed with
each batch to validate the approach. Once quanti-
fied, aliquoted samples may be diluted to the desired
concentration with the addition of appropriate buf-
fers, in preparation for sample loading.
The final step in processing samples requires the
denaturing (unfolding) of secondary/tertiary struc-
tures in proteins, allowing separation based on the
primary amino acid sequence theoretically in accor-
dance to the predicted molecular weight. To do this,
standard concentrations of samples (acquired as
above) are mixed with Laemmli buffer (Laemmli,
1970), the composition of which serves a number of
important functions. Thiol containing cysteine resi-
dues form disulfide bonds, which govern protein
folding and stabilize the secondary/tertiary structure
of proteins (Creighton, 1988). The addition of a
reducing agent, typically b-MCE (DTT or TCEP
(tris(2-carboxyethyl)phosphine) may also be used)
cleaves disulfide bonds destabilizing the secondary
and tertiary structure, unfolding the protein (Anfin-
sen, 1973). Due to the volatility of b-MCE, its addi-
tion should occur immediately before use.
Furthermore, high concentrations of b-MCE or
other denaturing agents (i.e., DTT) can interfere
with protein assays and therefore should be added
post protein quantification (Krieg et al., 2005).
Finally, to allow separation through the application
of an electrical current, all protein R-groups (func-
tional amino acid groups) are coated with negative
charges through addition of SDS. As SDS binds to
the primary structure of proteins (1.4 g per 1 g of
protein), the overall charge of the protein becomes
relative to its molecular weight, and it is this that
forms the basis of the established separation of pro-
teins through a polyacrylamide gel matrix (Smith,
1984).
Typically 10–100 lg of total cellular protein per
lane is loaded (Taylor & Posch, 2014); however, this
is generally within precast gels and will be deter-
mined by multiple factors. These will include the
thickness of the gel, and the lane width, requiring a
greater volume of sample. Nonetheless, the final con-
centration of protein to detect a given antigen should
be determined by the end user in accordance to
detection efficacy (i.e., via running titrations of pro-
tein). Although it is highly dependent on the protein
of interest, it is common for protein concentrations
of human muscle biopsies to be adjusted to 1–2 lg/
ll, with a total of 15–30 lg protein per lane being
typically loaded (Franchi et al., 2014). Proteins of
lower abundance within the sample may need
increased quantity to be loaded; for example, the
vitamin D receptor (VDR) is highly expressed within
the kidney, whereas within skeletal muscle, it is rela-
tively low requiring a greater amount to be loaded
(i.e., ~60 lg; Girgis et al., 2014). This can be
achieved by concentrating the sample (i.e.,
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evaporation or protein precipitation) or utilizing gels
with larger sample wells.
In order to have good resolution and identification
of the band(s) of interest, proteins are separated by
their mass (in accordance with their primary struc-
ture/AA sequence), as such it is essential to include
protein standards containing a mixture of predefined
proteins of known molecular weight markers to con-
firm the band of interest is the correct mass (Weber
& Osborn, 1969). Such standards are generally
loaded into the first and last lane of a gel. The choice
of standard will be dependent on the resolution
required near a molecular-weight region, along with
potential analysis requirements, such as confirmation
of the size of protein targets. Standards may already
be pre-stained for ease of visualization of separation
and confirmation of an effective transfer onto mem-
branes. Standards may also provide confirmation of
either 1°Ab or 2°Ab binding as they can contain
known binding sites for these targets and therefore
should produce detectable bands, e.g., a purified pro-
tein of interest. The inclusion of such internal stan-
dards allows the optimization of subsequent processes
through confirmation of antibody binding (Mahmood
& Yang, 2012). Therefore, SDS-PAGE systems may
be tailored to ensure optimal separation and resolu-
tion of the desired protein targets depending on their
molecular weight. Further to this, the inclusion of
specific molecular weight standards may be used in
conjunction with additional methods of confirmation
of sufficient separation (e.g., use of stain-free gels or
membrane staining, discussed below).
Polyacrylamide gel electrophoresis (PAGE)
Following these sample preparation steps, PAGE is
performed to separate out denatured and negatively
charged proteins based on their molecular weight.
Separation of protein samples within polyacrylamide
gels occurs due to the frictional resistance of a pro-
tein as it migrates through pores formed between
polymer chains within the gel (Ornstein, 1964). Poly-
acrylamide gels comprise polymerized acrylamide
monomers along with cross-linking N,N0-Methylene-
bisacrylamide monomers (Raymond & Weintraub,
1959), creating uniformly sized pores, dependent on
both monomer concentration and cross-linker ratio.
As an electrical current is passed, proteins move
through pores within the gel structure; as such, alter-
ing the bis-acrylamide concentration regulates pore
size and consequently the ability of larger proteins to
migrate. Gels with a higher acrylamide concentration
(e.g., 20%) impede the movement of larger proteins
to a greater degree than those of a smaller molecular
weight but better resolve those of lower molecular
weights (e.g., 4EBP1 ~20 kDa) (Chrambach & Rod-
bard, 1971). Similarly, if the desired target is a large
protein (e.g., mTOR ~289 kDa), a lower concentra-
tion gel (e.g., 7.5%) may be required for optimal res-
olution. Alternatively gradient gels (e.g., 4–12%)
provide uniform resolution across the molecular-
weight spectrum (Rath et al., 2013). Other gel
types such as agarose may be used, but are less
common as they are predominantly used for very
large molecular-weight proteins (e.g., titin isoforms
700–4200 kDa) giving superior separation when
compared to polyacrylamide gels (Warren et al.,
2003). Agarose gels may be hand-cast but require
storage at 4°C to prevent drying out. Other hand-
cast gels may also require use soon after casting and
may vary between runs due to the short shelf life of
some chemicals. The choice between commercial and
hand-cast gels is generally the preference of the user,
but commercial gels are generally more consistent.
Ultimately, the concentration of the cross-linking
molecules and the molecular weight of the protein(s)
of interest are the determining factors for gel choice
as taken together these will allow for efficient migra-
tion and optimal band resolution. The choice of gel
concentration and composition is mainly determined
by the molecular weight of the protein(s) of interest,
as it will allow efficient migration and optimal band
resolution.
Whereas electrophoresis of nucleic acids utilizes a
constant pH within the buffer and gel to achieve dis-
cernable separation (Westermeier, 2005), protein
samples require a discontinuous buffer system (Orn-
stein, 1964). Discontinuous systems utilize gels sepa-
rated into two regions, comprising a “stacking gel”
above a “resolving or separating gel” with larger and
smaller pores, respectively. Discontinuous systems
are designed to focus protein samples and allow clear
resolution of proteins. Initially, proteins migrate
quickly through the large pore stacking gel until they
reach the resolving gel, whereupon the smaller pore
size slows migration, causing the proteins to stack
together into compact bands (Ornstein, 1964). The
second principle utilizes the electrophoretic migra-
tion of both ions and proteins through a pH-buffered
solution. Chloride ions present within the gel have a
higher mobility and therefore migrate faster than
denatured proteins, establishing a leading ion bound-
ary (Ornstein, 1964). Within traditional Tris-HCl
stacking gels (pH 6.8), a trailing boundary of glyci-
nate ions form behind migrating proteins due to
reduced mobility at a low pH (Walker, 1994). Ulti-
mately, migrating proteins are sandwiched between
the two ion boundaries, stacking the sample into
tightly focused bands, whereupon they migrate into
the resolving gel containing smaller pores, slowing
the progression of proteins dependent on their size as
previously mentioned. Tris-HCl resolving gels are
typically formed at pH 8.8; this higher pH allows the
ionization of the trailing glycinate, increasing its
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mobility (Ornstein, 1964). Consequently, both chlo-
ride and glycinate boundaries will migrate past the
protein samples, no longer constricting them into
focused bands, allowing the unimpeded separation
of proteins. Alternative gels and discontinuous buf-
fer systems are available that may be better suited to
the resolution of either larger or smaller molecular-
weight proteins depending on sample composition.
For example, Bis-Tris systems utilize different buf-
fers containing either 3-(N-morpholino)propanesul-
fonic acid (MOPS) or 2-(N-morpholino)
ethanesulfonic acid (MES), which function as trail-
ing boundary ions instead of glycinate (Hachmann &
Amshey, 2005). These allow greater resolution of
mid-sized (~75 kDa) or smaller (<36 kDa) proteins
with MOPS or MES, respectively. Bis-Tris gels are
cast at pH 6.8, offering significantly longer shelf life
compared with Tris-HCl gels as they do not undergo
acrylamide hydrolysis due to their acidic nature.
Generally, electrophoresis is undertaken using a con-
stant voltage, rather than a constant current, due to
the linear relation of protein migration and voltage.
As current is dependent on the voltage and resis-
tance, a constant current will not control protein
migration as changes in resistance (i.e., warming of
the buffer) will cause the voltage to fluctuate.
Depending on the apparatus, electrophoresis is typi-
cally performed for 60 min with a constant voltage
of 200 V to give a suitable separation of protein
lysates; however, less time may be required for smal-
ler molecular-weight proteins.
Electrotransfer
Following the separation, the proteins are elec-
trophoretically transferred to a membrane (elec-
troblotting; with high affinity for protein), thereby
immobilizing the separated proteins, allowing subse-
quent probing with antibodies, and providing addi-
tional durability compared to gels (Towbin et al.,
1979). Utilizing the same principle as PAGE, the
negatively charged proteins in the gel are transferred
across onto the membrane when a lateral electric
current is applied while immersed in a buffered solu-
tion (termed wet transfer). The membrane is placed
directly upon the gel ensuring a mirror image trans-
fer of proteins occurs. Proteins are typically trans-
ferred onto nitrocellulose or polyvinylidene
difluoride (PVDF) membranes; originally nitrocellu-
lose membranes were used for their immediate bind-
ing and immobilization of proteins (Towbin et al.,
1979; Burnette, 1981). As nitrocellulose membranes
are not hydrophobic, they are easily hydrated for use
within wet or semi-dry transfers. However, nitrocel-
lulose membranes can be fragile, making them
incompatible with the current commonplace prac-
tices of stripping and re-probing for alternative
proteins (discussed later in stripping and re-probing).
The development of more durable hydrophobic
PVDF membranes allows the possibility to strip and
re-probe, as they are more chemically inert and
robust (Kurien & Scofield, 2006). PVDF membranes
bind proteins through hydrophobic interactions
(MacPhee, 2010) and are capable of binding greater
amounts of protein (~150 lg/cm2) than other sub-
strates (Matsudaira, 1987). Although the use of
PVDF membranes may be advantageous in captur-
ing greater amounts of protein, membrane–antibody
interactions are more likely to occur, generating
higher backgrounds when exposing the blots, conse-
quently increasing the importance of performing
thorough wash steps (Mahmood & Yang, 2012). The
hydrophobic nature of PVDF membranes requires
an initial pre-soaking in methanol to allow the infil-
tration of the buffer and the binding of proteins
(Mansfield, 1995). Another variable to consider is
the choice of pore size (i.e., 0.45–0.025 lm) of the
membrane, as this will affect the binding of larger or
smaller proteins (Burnette, 1981; Tovey & Baldo,
1987). Smaller proteins, such as cytochrome C
(12.5 kDa), have been shown to have a reduced
binding capacity upon membranes with a pore size
of 0.45 lm (Burnette, 1981). Thus, to probe for
smaller molecular weight proteins (<20 kDa), a
smaller pore size membrane is advisable as this will
bind larger quantities of protein. It is important to
note that protein transfer onto PVDF membranes
may be inhibited by high SDS concentrations
(Mozdzanowski et al., 1992), so prior to transfer gels
should be thoroughly washed in distilled water (e.g.,
2 min for thin gels), and then equilibrated in transfer
buffer (e.g., 5 min) to remove excess SDS.
Methods of transfer are numerous. Traditional
wet transfers involve successive layers of a cassette
backing, fiber pads, blotting paper, the polyacry-
lamide gel, the chosen membrane, blotting paper,
and the cassette front being “sandwiched” together
and submerged between an anode and cathode
within a transfer tank (Towbin et al., 1979; Burnette,
1981). The transfer process as described by Burnette
(1981) was achieved over 22 h; however, this dura-
tion is dependent on the size of the protein(s) of
interest. Insufficient transfer time will result in weak
signal or no intensity, as significant quantities of pro-
teins will remain within the gel. Conversely, excessive
transfer time will generate a poor signal as proteins
pass through both gel and membrane; however,
PVDF membranes generally have smaller pores com-
pared with nitrocellulose, reducing the amount of
protein passing through. As with electrophoresis, the
rate of protein movement is dependent on its molec-
ular weight, and thus smaller proteins may require
less time for transfer. Gel staining allows the evalua-
tion of transfer efficiency, through visualization of
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protein remaining within a gel (e.g., using Coomas-
sie/silver/Ponceau stains or stain-free gels), removing
some aspects of transfer uncertainty (Colella et al.,
2012). Other transfer techniques such as semi-dry
transfers are frequently utilized as they can offer fas-
ter transfer times (reduced to just over an hour),
depending on individual requirements or time con-
straints (Kurien et al., 2015). Most of the conven-
tional commercial systems are easy to use, reliable
for transfer of proteins of a wide range of sizes, and
use relatively inexpensive reagents. Still faster trans-
fers may be attainable using recently developed sys-
tems such as the Trans-Blot TurboTM Transfer
System, but these may not work well with some pro-
teins (i.e., <100 kDa) and require more expensive
consumables.
The composition of the transfer buffer will also
dictate the efficiency of transfer, especially for pro-
teins of a high molecular weight. Generally, wet
transfer solutions are buffered to pH 8.3 and con-
tain Tris-base along with glycine (Towbin et al.,
1979). It is important to note that the buffer pH
should not be adjusted through the addition of
acidic or basic solutions, as this will result in higher
conductivity through greater ion content, thus
increasing the temperature of the solution and
potential background interference and/or inefficient
transfer. These buffers may be pre-chilled to prevent
overheating, due to the high current, and the defor-
mation of the membrane, with transfer tanks com-
monly containing ice blocks. Methanol was used
within the original transfer buffers (Towbin et al.,
1979; Burnette, 1981) as it increases the ability of
membranes to bind proteins and prevents gel swel-
ling. However, since the inclusion of methanol
within these buffers may decrease the transfer of lar-
ger molecular-weight proteins (>100 kDa) as it
reduces the pore size of within gels (MacPhee,
2010), it may be advisable to exclude methanol
when probing for larger proteins. For the majority
of proteins analyzed via WB techniques, low-ionic
strength buffers and low electrical currents are opti-
mal (Alegria-Schaffer et al., 2009). If these generic
rules are followed, then successful transfer is highly
likely. Reversible staining of the membrane and/or
gel with Ponceau, e.g., will reveal protein loading,
commercial systems for reversible staining also exist
and have been extensively validated for this purpose
(Antharavally et al., 2004; Alegria-Schaffer et al.,
2009). Unequal loading will be displayed as notice-
able differences in multiple protein band(s)/lane(s)
intensities, in this instance the variability may be
due to unequal sample protein quantities caused by
different sample concentrations, or mistakes in the
sample volume loaded into individual lanes. Protein
lysate concentrations should be reanalyzed to deter-
mine if it was the former. Without efficient and
complete transfer of proteins, accurate quantitation
and analysis will be compromised.
Blocking
Although one of the simplest technical steps to per-
form in the WB process, blocking is important as it
can prevent non-specific binding of antibodies (1°Ab
and/or 2°Ab) to the membrane (Jensen, 2012). As
membranes have a high affinity for binding proteins
and therefore antibodies, blocking reduces back-
ground in subsequent steps. Different solutions may
be used for this stage of the protocol, each having
their own benefits and limitations. Non-fat-dried
milk diluted in Tris Buffer Saline Tween-20 (TBST)
is often used and is cheap and widely available, and
milk proteins are not, however, compatible with all
antibodies. For example, it has been reported that
bovine serum albumin (BSA; normally 5%) should
be preferentially used for biotin and anti-phospho-
protein antibodies as milk contains casein, which is a
phospho-protein, and biotin, rendering it likely to
interfere with the WB as the phospho-specific anti-
body may cross-react with the casein present in the
milk (Mahmood & Yang, 2012). Awareness of this
issue is ever more relevant with the continued devel-
opment of numerous specific, non-cross-reactive
anti-phosphoamino acid antibodies. Although these
antibodies greatly enhance phosphoamino acid-spe-
cific analysis and negate the need for radioactive
reagents, i.e., 32P, high backgrounds have been
observed when these antibodies are used during
immunoblotting (Michalewski et al., 1999). Possible
explanations for this technical challenge include the
existence of phosphorylated proteins in various
blocking solutions (as alluded to above) or inappro-
priate membrane-blocking conditions. Work by
Michalewski et al. reported that the binding of anti-
phosphoamino acid antibodies to proteins and mem-
branes critically depended on blocking conditions,
with a combination of amicase (5%), BSA (5%), and
membrane-blocking agent (5%) to be most effective
in reducing non-specific binding (Michalewski et al.,
1999).
For the preparation of both milk and BSA, a 2.5–
5% weight: volume solution is most commonly used
(Crossland et al., 2013; Franchi et al., 2014), in
TBST or phosphate-buffered saline (PBS). The mix-
ing must be thorough and the solution should then
be filtered to prevent grains contaminating the blot
during development. A further (albeit less common)
option for blocking is using highly purified non-ani-
mal proteins (e.g., isolated casein), although these
are much less cost-effective. Appropriate guidance
on blocking conditions is usually provided by com-
mercial companies alongside the antibody-specific
information; however, because not all blocking
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conditions are suitable for all target proteins, valida-
tion and testing for each individual protein of inter-
est is always recommended (Spinola & Cannon,
1985). Whichever approach is chosen an optimal
blocking, buffer should improve the sensitivity of the
WB by reducing background and improving the sig-
nal-to-noise ratio (measured as the signal obtained in
a sample containing the target analyte vs that
obtained with a sample without the target analyte).
Ideally, a blocking agent will bind to all sites of non-
specific interaction, eliminating all background with-
out altering access/interaction to the protein(s) of
interest for antibody binding. The choice of blocking
agent should be based on the antigen itself and the
type of 2°Ab conjugation (see below). For example,
in assays where alkaline phosphatase conjugates are
used, TBST should be selected, as PBS will interfere
with these phosphatases due to the presence of
sodium phosphate (and in some solutions potassium
phosphate also). If PBS is to be used for intermediate
steps, the membrane should be sufficiently washed in
TBST to remove excess sodium phosphate before
addition of the substrate.
It is not only the choice of blocking agent that can
affect WB outcomes; volume of blocking agent and
indeed the incubation period for blocking (which
may vary from an hour to overnight; Gershoni &
Palade, 1983) are also important factors. Too little
blocking agent (low concentration) or too short an
incubation period will increase the potential for non-
specific binding of the 1°Ab to the membrane-bound
proteins which could result in excessive background
and/or reduced signal-to-noise ratio. Conversely, an
incubation period that is too long and/or uses exces-
sive blocking agent may interrupt antigen-antibody
interactions, also causing a reduction in signal-to-
noise ratio (Mahmood & Yang, 2012). In a compara-
tive study assessing the efficacy of commonly used
blocking protocols to minimize non-specific back-
ground and promote immunoreactivity of antibodies
(monoclonal, polyclonal or biotin-conjugated)
against a phospho-amino acids, the authors recom-
mended the use of a solution composed of 5% BSA,
5% Amicase (Sigma; a mixture of free amino acids
with virtually no unhydrolyzed peptides and minimal
inorganic components), and 5% membrane-blocking
agent in Tris-buffered saline containing 0.05%
Tween 20 [to aid in the removal of residual SDS
from earlier steps (Zampieri et al., 2000)] for 45 min
at room temperature to achieve good-quality low
background WB (Michalewski et al., 1999). As with
most common blocking agents (Gershoni & Palade,
1983), incubation for longer than 1.5 h led to
reduced signal strength (signal to noise), with 30 min
or less resulting in unacceptably high backgrounds.
Therefore, in our experience, initial optimization is
undertaken using a 5% milk solution in TBST for
1 h, whereupon the background levels are assessed
and concentrations/blocking agent subsequently
altered. No single blocking agent is ideal for every
WB assay as each antigen-antibody pairing has
unique characteristics. Consequently, the chosen
blocking strategy must be optimized for each individ-
ual application, with the above considerations being
kept in mind.
Primary antibodies and determining specificity
The principle of the WB is the detection of protein(s)
through the binding and recognition of antibodies
(Ab) to one or more targets; this interaction should
be highly specific between a portion of the antigen
(protein) or epitope and the specific recognition sites
found on the fragment antigen-binding (Fab) region
of the antibody termed a paratope (Kurien et al.,
2011) (Fig. 1). The 1°Ab should be thoroughly
assessed and validated to be specific and sensitive
enough to detect the intended target protein. It is
important to check that the antibody is specific
toward the native or denatured protein, as the dena-
turing treatment of protein samples prior to SDS-
PAGE may alter the exposure and availability of the
epitope, affecting antibody binding affinity. In some
cases, it may be necessary to use “native-specific”
monoclonal antibodies (Tino et al., 2000). The tar-
geted peptide sequence may be available from the
supplier to allow confirmation of specificity and
region of binding; however, occasionally this may be
unavailable proprietary information. Traditionally
1°Ab are produced through immunization of the
host using purified target proteins, whereas modern
approaches utilize synthetic peptides, often produc-
ing Ab toward short denatured 8–10 amino acid
sequences. Isolation and purification is generally
achieved through affinity chromatography isolating
antibodies and small proteins and/or anion-exchange
filtration depending on the class (i.e., IgG, IgM)
(Clezardin et al., 1986). Predicted and confirmed
species cross-reactivity information is often only
available through the vendor; however, binding will
entirely depend on the antigen region. When choos-
ing a 1°Ab, there may be multiple forms available
from different vendors, ideally each would bind to a
unique antigen upon the protein of interest, allowing
accurate assessment of the protein’s abundance.
However, this is often not the case, and assessment
of the previous literature utilizing that antibody is
strongly advised. Some proteins may be orthologous
and contain the same or similar sequence to other
species. Thus, if a 1°Ab is specific to an epitope with
this sequence, it may be used to probe other species
(i.e., GAPDH 1°Ab may be used on human, rat, and
mouse tissue). Depending on the protein of interest,
extensive testing of multiple antibodies may have
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already been undertaken, allowing the most suitable
antibody to be selected. For example, the VDR has
low expression within skeletal muscle, and in order
to find a 1°Ab capable of detecting it by WB and
immunofluorescence, extensive validation of a panel
of multiple 1°Abs was required (Wang et al., 2010).
The identification of a highly specific VDR 1°Ab (D-
6; Santa Cruz Biotechnology, Cambridge, UK) was
confirmed and is believed to be the most representa-
tive. Assessment of new antibodies for a target anti-
gen requires even more careful testing, including the
use of a variety of appropriate positive and negative
controls (discussed below).
Specificity and performance of the 1°Ab antibody
is also dependent on whether it is monoclonal (mAb)
or polyclonal (pAb). Both have disadvantage/advan-
tage; pAb are produced from differing B-cell lin-
eages, recognizing multiple epitope regions on an
antigen. They are generally more cost-effective (Lip-
man et al., 2005) and provide more antibody mole-
cules that can target the protein of interest,
producing potentially a greater level of sensitivity
upon analysis (MacPhee, 2010). However, their
specificity can also be compromised, due to greater
possibility of non-specific binding (MacPhee, 2010).
In contrast, mAb provide highly consistent and
specific binding to a specific and known epitope on
an antigen, as they are produced from a single cell
lineage, raised against a single specific epitope (Lip-
man et al., 2005; MacPhee, 2010). Yet binding affini-
ties of mAb can suffer if the epitope structure is
affected in any way through denaturing or elec-
trophoresis for example (Lipman et al., 2005).
Depending on the primary amino acid sequence of
the target protein, similar epitopes may be present
within degradation products or alternate isoforms,
potentially presenting additional bands. Degradation
products will migrate ahead of the band of interest,
due to the decreased molecular weight. 1°Ab affini-
ties toward alternative isoforms may not interfere
with data interpretation if the bands are sufficiently
separated (i.e., have different molecular weights).
For example, certain antibodies toward P70 S6K1
(70 kDa), a critical protein in the mRNA transla-
tional initiation pathway and one of the most probed
of all in the muscle and exercise field, may bind to
the isoform P80 S6K (80 kDa). P80 S6K encodes a
nuclear localization signal and contains an addi-
tional 23 amino acids and would be present above
P70 S6K1 when blotted (Thomas, 1993). Nonethe-
less, sufficient electrophoretic separation between the
two isoforms and appropriate controls may allow
correct identification. For example, insulin-treated
L6 myotubes increased P70 S6K1 phosphorylation
(Somwar et al., 1998) but not P85 S6K allowing, in
this instance, identification of the correct band;
nonetheless, this does not guarantee specificity.
However, the assessment of a bands molecular
weight may not always be suitable, as some proteins
may migrate to a non-predictable region. For
instance, the mTOR regulator REDD1 has a pre-
dicted molecular weight of 25 kDa; however, it is
detectable at 35 kDa due to multiple lysine residues
(increased positively charged residues) (Chang et al.,
2009). This highlights the importance of knowing the
migrating properties of the target protein, and if
unexpected bands occur, literature investigation may
be required.
In order to validate the specificity of a new 1°Ab,
it should be tested against a positive lysate or puri-
fied protein control, giving a detectable band at the
correct molecular weight and a negative sample from
a tissue known not to express the intended target
[The Human Atlas provides reliable protein expres-
sion data (http://www.proteinatlas.org)], resulting in
no detectable band. Sometimes, it may be appropri-
ate to include a specific knock-in/out (e.g., via
shRNA or siRNA) sample to allow confirmation of
a target within the same tissue type. For example,
overexpression of AKT isoforms (an essential signal-
ing protein for muscle hypertrophy/atrophy) within
rat skeletal muscle following shRNA produced
detectable bands at the predicted molecular weight
(~40 kDa) compared with control samples (Cleasby
et al., 2007). Conversely, knockdown of AKT, again
within skeletal muscle, demonstrated a reduction in
band intensity at the same molecular weight com-
pared with control samples. Similarly protein inhibi-
tors (e.g., LY294002, rapamycin, etc.) known to
block specific phosphorylation pathways can be
used. For example, the addition of LY294002 to cul-
tured cells inhibits PI(3)K, resulting in decreased
phosphorylation of down-stream intermediates (i.e.,
AKT/P70 S6K1) (Rommel et al., 2001). Thus, if
probing for phosphorylated P70 S6K1, cultured L6
cells treated with/without insulin and LY294002 will
provide a robust positive (greater band intensity)
and negative control (reduced intensity), respec-
tively, compared with untreated samples. In this
instance, the inclusion of an untreated sample along-
side an inhibited negative control will confirm the
reduction in band intensity is in fact due to decreased
expression, rather than a loss of detection. Despite
rigorous testing of antibodies with appropriate posi-
tive/negative controls, additional bands may still be
present or insufficiently separated making identifica-
tion and quantitation of the correct band (if present)
unreliable. Absolute confirmation of the presence of
a protein in a given band may be achieved by mass
spectrometry via determination of the peptide
sequence (Trauger et al., 2002). Briefly, the band of
interest is excised and the mixture of proteins
digested by trypsin into small peptide sequences cap-
able of being sequenced by liquid chromatography–
11
Technical aspects of Western blotting
mass spectrometry (LC-MS/MS). Utilizing this
approach, however, requires access to highly specific
and costly equipment and technical expertise, but
can provide validation of antibody specificity. Ulti-
mately, positive and negative controls will help
establish the degree of non-specific binding and
potential false-positive bands, along with the confir-
mation of increased/decreased protein expression,
giving confidence that the highlighted band is indeed
the correct one.
Post-translational modifications
Crucial for determining the relative importance of
potential signaling mechanisms is the ability to detect
PTMs such as the alterations in reversible phosphory-
lation states of various proteins (phosphoproteins).
The phosphorylation of a protein will alter multiple
aspects of its interactions, including localization,
conformational shape, hydrophobicity, and activity
(Polyansky & Zagrovic, 2012). Phosphospecific-anti-
bodies capable of distinguishing between short epi-
topes containing phosphorylated or unphosphorylated
amino acid residues, typically Thr, Ser, and Tyr have
been developed (Nairn et al., 1982). Proteins may also
be phosphorylated at multiple loci through different
signaling mechanisms, and thus it is important to
choose the correct phosphorylation site, depending on
the pathway or response of interest. For example, the
activity of eukaryotic translation initiation factor 4E
(eIF4E), a subunit of eIF4F (eukaryotic translation
initiation factor 4F), crucial for the initiation of pro-
tein synthesis is regulated through the phosphorylation
of 4E-BP1 (eIF4E binding protein 1). 4E-BP1 is phos-
phorylated by FRAP/MTOR at Thr37/46, but
requires additional phosphorylation at Ser65 and
Thr70 to disassociate from eiF4E (Gingras et al.,
1999). Simply measuring changes in Thr37/46 phos-
phorylation may be inadvertently misleading, as addi-
tional phosphorylation may be required for activation
(Gingras et al., 1999). In this case, both phosphoryla-
tion sites (i.e., 37/46 and 65/70) should be probed for
when investigating changes in potential signaling
mechanisms of protein synthesis.
A myriad of other PTMs have important roles on
various physiological states including but not limited
to ubiquitination (Paul et al., 2012), glycosylation
(Pere-Brissaud et al., 2015), and methylation
(Voelkel et al., 2013), and changes may be assessed
via WB. For example, starvation-induced skeletal
muscle atrophy and protein degradation are associ-
ated with an increase in ubiquitinylation of proteins
(Paul et al., 2012). This may be assessed using a
1°Ab targeting ubiquitin that will bind to multiple
ubiquitinated proteins throughout a blot. Thus, in
samples from starved or atrophying muscle, the band
intensity of the lane will be increased compared with
control samples, demonstrating increased protein
ubiquitination, suggestive of increased proteolysis.
This assessment of ubiquitination needs to be accom-
panied by separate measures of proteins involved
within the proteolytic process, such as FoxO3 and
AKT, confirming (or otherwise) increases and
decreases in phosphorylation levels in atrophic mus-
cle samples (Zhao et al., 2007). This same principle
of detecting the incorporation of a label onto multi-
ple proteins permits the monitoring of the translation
process, e.g., using puromycin in cell culture or pre-
clinical models (Schmidt et al., 2009). Here, puromy-
cin, a structural analog of aminoacyl tRNAs, is
incorporated into newly synthesized proteins, which
are subsequently probed using an anti-puromycin
1°Ab. Measuring lane intensity provides a semi-
quantitative assessment of global protein synthesis
(Schmidt et al., 2009). As previously mentioned,
known signaling intermediates (i.e., AKT/P70 S6K1)
need to be assessed to ensure that changes to puro-
mycin incorporation are matched to increased ana-
bolic signaling (Crossland et al., 2013). Ultimately, a
1°Ab may be specific for a single phosphorylated
protein or for a specific PTM component such as
ubiquitin that may be present within multiple pro-
teins. Thus, even within the same sample, assess-
ments of signaling cascades (phosphorylation),
protein degradation (ubiquitination), or protein syn-
thesis (puromycin incorporation) may be made,
allowing a comprehensive investigation of protein
metabolism. Further PTMs may be assessed by WB
such as glycosylation of a protein, which has a sub-
stantial impact upon multiple aspects, including pro-
tein folding, conformational changes, and stability
along with solubility (Rudd & Dwek, 1997). The two
major forms of glycosylation are serine/threonine O-
linked or asparagine N-linked carbohydrates. This
will increase the molecular weight of the glycopro-
tein, and the degree of glycosylation can be assessed
by initially treating samples with a endoglycosidase
(e.g., PNGase) to remove N-linked glycans. As a
result of removing the carbohydrate moieties, addi-
tional bands will be detected at a lower molecular
weight (Pere-Brissaud et al., 2015).
Secondary antibodies
Secondary antibodies (2°Ab) are required for the
indirect detection of a target antigen bound by a
1°Ab. Typically 1°Ab will not be conjugated to a
label for detection, resulting in the need for 2°Ab
(conjugated to a reporter function, e.g., horseradish
peroxidase [HRP], specific fluorophores) capable of
binding to the fragment crystallizable (Fc) region on
a 1°Ab, allowing subsequent detection by a camera
or imaging device (discussed below). The crucial
aspect of utilizing a 2°Ab is the ability to amplify the
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detectable signal since multiple 2°Ab can bind to a
single 1°Ab, thus amplifying the detection of low
abundant proteins. The choice of 2°Ab will initially
depend on the 1°Ab isotype and which animal it was
raised within (Lipman et al., 2005). Variations
within Ab heavy chain formations will determine
their function and class; antibodies from mammals
will be one of five classes, IgM, IgD, IgE, IgA, or
IgG, with the latter being subdivided into multiple
subclasses within rats, mice, and humans (i.e., IgG2a,
IgG2b) (Lipman et al., 2005). Primary Ab raised
within mice or rats may require isotype-specific
2°Ab; however, rabbits produce only a single isotype
of IgG, allowing broad specificity 2°Ab to be utilized
(Manning et al., 2012). For example, an IgG 1°Ab
raised within a rabbit simply requires an anti-rabbit
IgG, whereas a mouse IgG2a would require a 2°Ab
specific for the IgG2a isotype. As rabbit 1°Abs suitable
for WB purposes are common, this means a single
anti-rabbit IgG 2°Ab may serve for multiple targets.
However, the use of 1°Ab from different species
allows the unique potential for multiplex detection
using 2°Ab conjugated to different fluorescent wave-
lengths for multiple detections upon the same blot
(discussed below) (Gingrich et al., 2000). For exam-
ple, a rabbit IgG 1°Ab specific toward AKT (60 kDa)
may be probed for along side a mouse IgG2a 1°Ab for
P70 S6K1 (70 kDa) using a red fluorescent anti-rabbit
IgG (594 nm) and green fluorescent anti-mouse IgG2a
(488 nm). An additional key aspect is the ability to
simultaneously probe for both total and phosphory-
lated expression levels (e.g., pan-AKT vs AKT
Ser473) providing 1°Ab are raised in differing species
and the epitope regions do not overlap (Georgopoulos
et al., 2010). The ratio between these measures gives
an indication of a proteins capacity for signal trans-
duction (total) vs activation (phosphorylation), as
discussed below. Ultimately, the use of different spe-
cies-specific fluorescent 2°Abs in a single incubation
potentially allows the measurement of two or more
targets (i.e., total vs phosphorylated or targets of a
similar molecular weight) within the same blot.
Although 2°Ab are raised toward specific epitopes
upon the 1°Ab, cross-reactivity may occur with other
separated proteins or indeed those used for blocking,
due to similar peptide sequences (Ramlau, 1987).
Therefore, negative controls should also be under-
taken by omitting the 1°Ab incubation to ensure the
observed bands are not the result of non-specific
binding of 2°Ab. The optimal dilution of the 2°Ab
will depend on the expression level of the target pro-
tein and the choice of 1°Ab (e.g., GAPDH is highly
expressed, requiring higher dilutions to prevent sig-
nal saturation); however, the manufacturer’s recom-
mendation is often a good starting point. A dilution
curve may then used to optimize the concentration
needed for the targets being investigated. The 2°Ab
solutions are typically made up within the same buf-
fer and blocking solutions as outlined previously,
but may require optimization if a high background
occurs. Unlike conditions for 1°Ab, secondary incu-
bations are generally undertaken at room tempera-
ture for a shorter amount of time, typically 1 h.
Occasionally, longer incubations may be required;
however, this can lead to increased non-specific bind-
ing within the membrane, generating a higher back-
ground. For ease of use, in our experience, altering
antibody concentrations for different targets, while
maintaining incubation times, is preferable.
Detection
The general principles of detection for WB are the
same as for other antibody-based assays, such as the
enzyme-linked immunosorbent assay (ELISA) (Vol-
ler et al., 1978). In general terms, the 2°Ab is conju-
gated with a labeled compound (i.e., radio-isotope or
fluorophore) or enzyme that permits subsequent
detection. Historically, this was a radioactive isotope
or enzyme exposed against X-ray film (Miura et al.,
2001) but now is normally an enzyme or a fluo-
rophore detected by camera (Crossland et al., 2013).
The two most commonly employed enzymes are
alkaline phosphatase (AP) (Bronstein et al., 1989)
and HRP (Kricka, 1991). Both AP and HRP can be
used for colorimetric or chemiluminescent detection.
When employing HRP, it is important to remember
that sodium azide inhibits this enzyme so solutions
like those used for blotting and detection should not
contain sodium azide, or membranes should be suffi-
ciently washed before exposure. In colorimetric
detection (Babson et al., 1966), a substrate (e.g., 3,30-
diaminobenzidine) of HRP is oxidized producing a
brown insoluble product. Quantification can then be
achieved by scanning the blot with either a dedicated
imager or traditional office scanner (although the lat-
ter is not recommended, as they are not designed to
have a large linear range) and analyzing band inten-
sity using freely available software such as NIH
Image J (http://imagej.nih.gov/ij/). A key disadvan-
tage of this form of detection is that the chemical
reaction must be stopped, and therefore, optimal
reaction conditions need to be determined (reaction
time, temperature, etc.) prior to quantitation.
With chemiluminescent detection (Kricka, 1991),
HRP luminol is oxidized in the presence of hydrogen
peroxide producing 3-aminophthalate, which emits
light at 425 nm. A chemiluminescent blot is opti-
mally imaged after 3–5 min of incubation with the
substrate and may produce a signal for several hours
(Alegria-Schaffer et al., 2009). A key advantage of
this form of detection is that the blot can be repeat-
edly rinsed and exposed to substrate and luciferase
to allow multiple exposures, which is useful for
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optimization of detection parameters, thereby ensur-
ing the blot is not underexposed or overexposed.
However, a potential disadvantage is that the blot
must either be exposed to film, which must then be
developed, or be placed in a specialized detection sys-
tem (e.g., Chemidoc, OdysseyTM) with the latter being
the most common and accurate approach. Both
options for visualization of the blot, however,
require more expense and equipment than for colori-
metric detection. Quantification of the blot will be
dependent on the light detection method. If photo-
sensitive film was exposed and developed, subse-
quent scanning and Image J are commonly
employed. More commonly, a specialized detection
system, typically utilizing proprietary software,
employing densitometry analysis will be used. The
proper storage and age of buffers, substrates, stop
solutions, and luciferase solutions must similarly be
considered as degradation and/or contamination of
any one of these can affect each of the steps and
potentially prevent detection and/or result in very
high background signals. It is also important that
the 2°Ab has been properly stored (80 °C, 20 °C,
4 °C) and is reasonably fresh, as the enzymes will
degrade with time. If stored correctly, antibodies
may still be viable for multiple years (Argentieri
et al., 2013); however, suppliers only recommend
storage for approximately a year as extended storage
will decrease its effectiveness.
These aforementioned limitations can be overcome
using fluorescent detection where the 2°Ab is conju-
gated to a fluorophore. For this type of detection, no
further chemical reactions are required, and the blot
can be visualized after exposure to 2°Ab and rinsing.
However, it does require further specialized imaging
systems. Fluorescent-based imaging has a greater
upper linear range of detection (250–500 pg) com-
pared to chemiluminescent (125 pg) (Gingrich et al.,
2000). Fluorescent antibodies also have a similar
lower range when compared to chemiluminescent
detection and so may be more appropriate when
investigating higher abundance proteins. A further
benefit of fluorescent antibodies is the ability to uti-
lize 1°Ab from different species and subsequent dif-
ferent wavelength 2°Ab for each to perform
multiplexed exposures upon the same blot (discussed
previously) (Gingrich et al., 2000). This crucial dif-
ference can allow the probing of multiple targets
with similar molecular weights (e.g., AKT and P70
S6K1) or PTMs (e.g., pan-AKT vs AKT Ser473)
using different conjugated fluorophores, specific to
different excitation channels (e.g., 594 nm vs
488 nm) (Georgopoulos et al., 2010). When it is
desirable to improve the sensitivity for the detection
of low abundance target proteins, a couple of
approaches may be employed. First, switching detec-
tion systems may help as fluorometric detection is
generally similar to chemiluminescent, whereas
chemiluminescent detection is more sensitive and
produces signal at lower concentrations than colori-
metric. Second, just as using a labeled 2°Ab boosts
the signal compared with using a labeled 1°Ab, use
of a labeled tertiary antibody can boost signal by
providing additional amplification (Delaive et al.,
2008).
Stripping and re-probing
The stripping and re-probing of WB membranes pro-
vides a time-efficient method for determining multi-
ple protein targets within a single gel run (Sennepin
et al., 2009). It allows a number of different analyses
on a single membrane, thus saving time, sample and
consumables, and maximizing efficiency. Further-
more, there may also be times where a membrane
requires probing with a 1°Ab to confirm the data
obtained from the initial analysis of the protein of
interest (i.e., a different 1°Ab specific to another epi-
tope on the same protein) (Kaufmann & Shaper,
1992).
Initially developed in the early 1980s, these meth-
ods involved incubation in either urea, b-MCE/BSA
buffers (Erickson et al., 1982), or highly acidic gly-
cine buffers (pH 2.2; Legocki & Verma, 1981) at ele-
vated temperatures for long periods (up to an hour
in some cases), in order to remove the 1°Ab and
detection reagent (e.g., enhanced chemiluminescence
[ECL]). Ultimately, multiple protein targets could be
detected within a single sample/run, since the 1°Ab
have been disassociated from their target proteins,
allowing other 1°Ab to be added (Yeung & Stanley,
2009). Since these early experiments, stripping buf-
fers have progressed rapidly and many commercial
preparations exist which claim to be gentler (gener-
ally consisting of a mixture of SDS, glycine, and
detergents; TBST) and work rapidly (<15 min) at
room temperature. However, it is always recom-
mended to check the efficiency of these commercial
buffers, by re-exposing the membrane with ECL
reagents or other detection methods post removal of
the antibody.
Stripping and re-probing is commonly undertaken
to investigate the levels of phosphorylated proteins
before assessing the total expression of the same pro-
tein (Figueiredo & Nader, 2012), allowing the signal-
ing capacity vs activation to be assessed (discussed
below). In doing so, the generally weaker expressed
phospho-protein is first detected, allowing accurate
measurement, before the total is probed. Despite the
obvious benefits of stripping and reprobing of mem-
branes, these methods are not always foolproof and
can have significant limitations. First, care must be
taken as to which protein the membrane is re-probed
for following stripping, as it is difficult to eliminate
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detectable signal from highly abundant proteins.
Additionally, if the stripping buffer has failed to
completely remove all antibody and ECL from the
membrane, and the two proteins of interest are of
similar molecular weights [e.g., GAPDH (molecular
weight: 35.8 kDa, but band commonly detected at
37 kDa) and ERK 1/2 (molecular weights: 42/
44 kDa, respectively)], then the signal from the inef-
fectively stripped antibody may interfere with the
subsequent detection and quantification of the sec-
ond target protein. Further to this, stripping of the
membrane cannot be performed indefinitely. As a
rule of thumb, only three stripping incubations are
recommended, due to loss of the antigen (Sennepin
et al., 2009). This limits the number of targets that
can be probed from the same membrane but is still
worth doing considering the benefit of measuring
two or more targets within the identical sample.
There are, however, a number of recent develop-
ments which have aimed to enhance the capacity for
multiple Ab detection from the same membrane.
Sennepin et al. (2009) described a technique whereby
instead of removing or stripping the HRP activity
linked to the Ab from the membrane, this is instead
irreversibly inhibited with hydrogen peroxide, to
allow up to five different sequential incubations/de-
tections to be performed on the same membrane
(Sennepin et al., 2009). There are suggestions, how-
ever, that the exposure to such strong oxidizing con-
ditions may alter certain epitopes, potentially
affecting Ab recognition (Kaufmann, 2001). A simi-
lar procedure can also be performed using sodium
azide, which has been proposed to avoid this epitope
issue; however, the method requires lengthy incuba-
tions of upwards of 16 h compared to 15 min with
hydrogen peroxide, and as sodium azide is known to
inhibit HRP detection, it may interfere with subse-
quent detection (Kaufmann, 2001). As previously
discussed, both colorimetric and chemiluminescent
approaches may utilize HRP-conjugated 2°Ab, and
both may be utilized separately in the same blot for
different targets (Kar et al., 2012). Initially, the
weaker target is blotted for using colorimetric
3,30,5,50-Tetramethylbenzidine detection before heat-
ing in a b-MCE containing buffer before re-probing
for the additional target with ECL detection.
Care should be taken with these methods and con-
ditions should always be optimized; in addition, it
should also be demonstrated that stripping and
re-probing does not adversely influence subsequent
quantification. Thus, the undertaking of stripping
and re-probing must be carefully considered as the
probable loss of an antigen may in fact lead to erro-
neous measurements. This becomes more important
when changes in protein expression are small or
gradual (i.e., time-course experiments). However, the
ability to measure both the phosphorylated and total
expression of the same protein within the same blot
is extremely desirable. Therefore, one must consider,
when performing WB, whether it is appropriate to
strip and re-probe a membrane, as despite the bene-
fits (phospho vs total protein), the limitations may
outweigh the benefit, and consequently the accurate
detection and quantification of WB data may only
be possible with repeated blots.
Analysis
Analysis of the bands of interest depends on the type
of detection and the imaging system available, with
many imaging systems requiring proprietary soft-
ware for image acquisition and quantification. Each
software package utilizes slightly different methods
for quantification; however, generally peak height or
area is used (Gassmann et al., 2009). During quan-
tification, it is essential to ensure that the bands of
interest are within the linear range of detection, as
pixel saturation on imaging sensors may occur
within highly abundant targets (Mollica et al., 2009);
this is quite a common error and can easily be
avoided. However, automatic detection of saturation
is now a standard feature within most imaging pack-
ages. If oversaturation occurs, it may be possible for
the sensitivity of the camera to be reduced (i.e.,
reduced pixel binning) increasing the image resolu-
tion (larger image, more pixels) and therefore requir-
ing more signal to achieve oversaturation. Despite
this, oversaturated “staining” of the membrane (i.e.,
as signified by visible yellowish bands on the mem-
brane prior to exposure) during chemiluminescent
detection by highly abundant proteins (e.g.,
GAPDH) may occur requiring the reduction of
either sample loading or greater dilution of the 1°Ab.
Another important consideration for quantifica-
tion is the choice of single band or whole lane boxed
analysis, with the former suitable for individual pro-
tein analysis, and the latter better for the detection of
global protein changes (i.e., ubiquitinated proteins
or puromycin incorporation). Single-band analysis is
undertaken simply through identifying sample lanes
before determining the band of interest, while whole
lane analysis will measure the intensity within a des-
ignated area (i.e., single lane) (Taylor & Posch,
2014). Whichever method is chosen, it must be con-
sistent throughout the blot, with an equal area of
analysis used per lane; otherwise different volumes
(size of the analysis box region) will be analyzed pro-
ducing potentially distorted data. Although WB con-
ditions will have been optimized to produce the
clearest bands possible, a visible background may
still occur, requiring background subtraction during
analysis (Gassmann et al., 2009). Principally, this is
achieved through subtracting the calculated back-
ground density from peak values; however, the
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different algorithms used to determine background
intensity may not be truly representative. One com-
mon method is the rolling disk algorithm, which
determines peak origins based on where a specified
disk could “roll,” typically the smaller the value
(smaller disk), the greater amount of background
becomes subtracted (Taylor & Posch, 2014). This
approach is better suited to prominent individual
bands since smaller, less intense bands may become
lost. Another method is to manually designate a
region of consistent background with no bands,
assigning that density value for background correc-
tion. This method may be more suitable for whole
blot analysis, with minimal fluctuation in back-
ground levels. Ultimately, the choice of analysis must
be representative of the visualized blot and within
the range of linear detection of the imaging method
employed.
Normalization of target protein abundance
To account for possible errors in sample preparation
and loading, normalization of samples to remove
inter sample/gel variation is paramount. It is typical
for specific “housekeeping” proteins (HKP) such as
glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) or b-actin to be probed for, acting as
internal loading controls assuming their expression
remains stable under the experimental conditions
used (Welinder & Ekblad, 2011). The HKP chosen
should be one that is known to stay constant between
control and experimental samples and demonstrated
to be unaffected by the treatment or intervention
undertaken. Errors such as loading more sample
within one well will increase the target signal, likely
skewing data interpretation. As such, target measure-
ments may be normalized to HKP values, removing
loading bias. However, the accuracy and effective-
ness of these HKPs are dependent on multiple factors
such as oversaturation of the protein, high back-
ground, and lack of linearity (McDonough et al.,
2014) and can easily suffer from technical errors
within the WB process (Eaton et al., 2013). One
study has demonstrated the linear range of up to
5 lg of loaded protein when probing for GAPDH,
showing no increase in band density at higher con-
centrations (Welinder & Ekblad, 2011). Other com-
mon loading controls (e.g., pan-actin and b-tubulin)
have also displayed poor linear ranges in the same
manner (Li & Shen, 2013). This lack of linearity may
be resolved by loading less protein but may reduce
the sensitivity to detect lower abundant proteins.
Expression of HKPs such as b-actin has also been
shown to be extremely variable between tissue types
(i.e., muscle, heart, fat) (Eaton et al., 2013). Alarm-
ingly, however, expression of b-actin has been
revealed to not be homogeneous within a single tissue
sample, being shown to differ between proximal and
distal regions of a single mouse sciatic nerve (Eaton
et al., 2013). Such differences in expression may
become more problematic within skeletal muscle as it
is a large complex tissue, with different regions
potentially responding differently to stimulation
(Seynnes et al., 2007), therein WB results only pro-
vide an average of expression changes within a single
sample. The use of a second HKP may help; how-
ever, some of the same issues may exist and it will
need to be demonstrated that the choice of HKP
does not affected the interpretation (Fig. 2). As a
result of the potential changes in HKP expression in
response to the experiment and the limited linear
range of some, the use of HKPs for normalization
may mask or confound potentially relevant changes
in protein expression.
A viable alternative to blotting for HKPs is to
assess the total amount of protein either within
stained or stain-free gels or on stained membranes
(Welinder & Ekblad, 2011; Eaton et al., 2013).
Assessing total protein offers distinct advantages
over HKPs as it is unbiased with respect to changes
in the expression of a single (or multiple) HKP, and
if utilizing stained membranes, also allows evalua-
tion of the blotting process and transfer quality
(Taylor et al., 2013). Coomassie staining a gel and
fluorescence detection has shown the existence of a
wide linear range (1–40 lg), negating previously dis-
cussed HKP linearity issues. Membranes may be
stained to visualize total protein by several methods
(i.e., Ponceau S, colloidal silver, India ink); however,
Coomassie staining is a common, simple approach
that has been demonstrated to be an unbiased
method of total protein assessment (when analyzing
total lane volume) with a high linear range of detec-
tion (2.5–25 lg) (Welinder & Ekblad, 2011). If one
of these approaches is chosen, the quantification of a
single random band that is consistent across each
lane may be used for normalization. In our experi-
ence, Coomassie staining a membrane is an effective
Fig. 2. Representative blots for multiple housekeeping pro-
teins and the Coomassie-stained membrane of IGF-1-trea-
ted C2C12 cells, demonstrating potential variability in
housekeeping proteins in response to a treatment.
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method of providing reliable quantification of total
protein that removes potential problems associated
with individual HKP expression. Staining the mem-
brane or gel allows appropriate quantification nor-
malization for whole lane analysis providing more
robust normalization approach for both ubiquiti-
nated proteins and puromycin incorporation, as dis-
cussed earlier.
The final aspect of analysis is the requirement to
calculate the changes in protein expression, resulting
from a treatment/intervention. Depending on the
experimental design, multiple blots may be required
to analyze all samples, and thus, subtle changes
within the process may influence the final data as
background or band density may be variable across
multiple blots. In this instance, a single quality con-
trol sample (typically pooled from multiple controls)
is loaded on each gel, providing a control sample
across all gels, allowing gel-to-gel comparisons to be
made. Dividing band values (i.e., band density) by
the quality control sample (as a correction factor)
normalizes differences in loading, separation, trans-
fer, and detection that may have occurred. This
should be undertaken for the values of the initial
protein(s) of interest (e.g., Pan-AKT, p-AKT Ser
473, or puromycin incorporation), along with the
normalization values (i.e., HKP or total protein).
Another approach typically used for human studies
is to use an initial basal sample for each individual to
assess changes in subsequent samples, permitting the
calculation of a fold change from the initial basal
levels. Whichever approach is chosen, it must be
applied consistently throughout analysis and may
depend on the total number of samples and compar-
isons needed (i.e., control vs treatment or control vs
treatment 1 vs treatment 2).
As previously mentioned, measurement of both
the total expression and phosphorylation status of a
protein (either by multiplexing fluorescent 2°Ab or
stripping and re-probing) is important. Determining
changes to a protein’s total expression in response to
a treatment or intervention indicates its capacity to
signal, since a greater abundance or protein will
allow a greater potential for signaling to occur. Mea-
surements of a protein’s phosphorylation status (i.e.,
signaling activation) may change through modifica-
tion of the individual proteins phosphorylation level
(Tremblay et al., 2007) or by alterations within the
total amount of protein available (Yung et al.,
2011). Consequently, the normalization of a phos-
pho-protein to its total expression allows the ratio of
phosphorylated proteins to be assessed (i.e., the rela-
tive proportion of phosphorylated vs non) (Wilkin-
son et al., 2008). For example, within skeletal
muscle, the total expression of various anabolic sig-
naling intermediates (e.g., AKT, P70 S6K1)
remained unchanged, while phosphorylation of these
proteins increased (Brook et al., 2015). As such, the
ratio of phosphorylated proteins to total expression
increased, demonstrating the increased proportion of
phospho-proteins. Importantly, however, if the treat-
ment undertaken increases both total and phospho-
rylation levels, this ratio may remain unchanged,
masking any potential mechanisms, and thus it may
be extremely important for both measures, i.e., total
and phosphorylation status, to be made simultane-
ously.
Presentation of representative blots
One essential aspect and ethical concern in the
reporting of scientific findings is the accurate and
representative presentation of WB data and example
images (for a more in-depth review see Rossner &
Yamada, 2004). Generally, WB data are presented as
both a graphical and representative image to demon-
strate the effect of the intervention and the quality of
blot. Herein lie ethical considerations in presenting
images that are required to present images that accu-
rately represent the quantified data (Rossner &
Yamada, 2004). For example, the splicing of images
from multiple blots to form one continual image
may obscure the magnitude of change between sam-
ples. If possible replicates from all experimental
groups should be run within the same blot to provide
a representative image; however, if this is not
Fig. 3. Examples of image manipulation techniques upon representative blots. (a) Multiple blots spliced together to give the
impression of a single blot. (b) An oversaturated blot with no clear distinction between bands of interest. (c) Contrast adjust-
ment masking additional bands. (d) Image manipulation to intensify, reduce, or remove bands.
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possible, clear distinction between blots should be
made (Fig. 3). Additionally, sample replicates should
be included within the images, demonstrating equiv-
alent changes in response to the intervention. The
inclusion of a representative loading control (i.e.,
Coomassie) is essential to demonstrate that changes
in samples are due to the intervention, rather than
protein loads. These are required to be from the
same blots as the other representative images and
should not be repeated unless the same gel has been
stripped and reprobed for multiple targets or differ-
ent molecular-weight targets were measured. As pre-
viously discussed, one method of validation of target
specificity is the knowledge of a correct molecular
weight. Despite this, it is common to crop represen-
tative blots to reduce their overall size. The addition
of an indicator of the precise molecular weight must
be included even if image cropping occurs to allow
identification. For example, when blotting for phos-
phorylated 4E-BP1, three isoforms typically form
distinctive bands (i.e., c, b, a) at differing molecular
weights (Elia et al., 2008). In this instance, each iso-
form should be indicated with the appropriate
molecular weight. Accordingly indicators of molecu-
lar-weight markers should be included to allow the
independent determination of a targets size and
specificity.
Representative images should clearly show indi-
vidual bands that are not over loaded/saturated. As
with any representative image for scientific publica-
tion, inappropriate manipulation may be regarded as
misconduct. Thus, manipulation of an image to
change the intensity of a band(s) or even to remove it
altogether is highly unethical (Fig. 3). If any alter-
ation of an image is made, it should affect the
entirety of the image (rather than a specific section)
and be clearly stated in the figure legend. Finally, the
inclusion of detailed information of the source of
both the primary and secondary antibodies is essen-
tial for reproduction in other laboratories along with
possible future discussion of antibody specificity.
Alternative and emerging methodologies to WB
Although this review focuses on the technical aspects
and choices to be made to undertake robust and
accurate WB measures, it is often important to uti-
lize additional complementary techniques to supple-
ment and support the data that WB generates. One
common approach is the use of an ELISA to quan-
tify the abundance of a target protein (total or phos-
pho) (Timen et al., 1976) although this method can
be expensive, requiring access to a plate reader.
Commonly, ELISAs use sample lysates containing
non-denatured native proteins (Dhingra et al.,
2011); however, this may not always be the case.
ELISAs offer distinct advantages such as being in
96-well plate format, increased sensitivity, relative
ease of absolute protein concentration (using
supplied standards), and reduced time consumption
(2–4 h), proteins of varying molecular weights can-
not be distinguished from one another, and this is a
crucial consideration that must be made as the 1°Ab
used may bind to multiple proteins producing a fal-
sely high signal. Additionally, ELISAs are not cap-
able of re-probing once completed, instead require
multiple plates to be run, thus potentially requiring
more sample than multiple WBs. Another emerging
technology is the use of protein arrays to detect the
presence of multiple target proteins within a single
sample (Huang et al., 2001), to explore potential
protein interactions with other proteins, and even
DNA and RNA, and to measure enzyme activity.
Utilizing the same principle as WB and ELISAs,
arrays typically contain individual spots of labeled
1°Ab immobilized to the array for multiple targets.
Although WB can provide important information on
modulation of signaling networks, potential targets
(or pathways) must first be identified, and develop-
ments within array kits allow the probing of dozens
of targets simultaneously within a single sample, pro-
viding lots of data with relative ease. Interesting
observations may then be further investigated using
traditional WB techniques. Although the use of ELI-
SAs is now commonplace, the use of mass spectrom-
etry (i.e., LC-MS/MS) for the analysis and extremely
accurate quantification of proteins is becoming more
widespread (Ryder et al., 2015). Mass spectrometry
offers distinct advantages over both ELISAs and tra-
ditional WB techniques as the distinction between
multiple protein isoforms is possible with a high
degree of sensitivity and over a wide dynamic range
(0.5–500 ng/ll) (Hu et al., 2005). However, such
analysis requires highly specialized, expensive equip-
ment and technical expertise not commonplace
within most labs. Mass spectrometry can be used in
conjunction with WB to undertake highly specialized
measures, e.g., to confirm antibody specificity, to
determine novel protein–protein interactions after
IP, and to uncover PT modifications (Mann & Jen-
sen, 2003).
Conclusions
WB has emerged as an essential tool within physio-
logical research; nevertheless with poor understand-
ing and implementation, any subsequent analysis can
produce misleading and confusing interpretation
(i.e., Ab specificity and validation). Before a sample
is loaded into a gel, careful consideration must be
given to often overlooked aspects such as the appro-
priate buffer for homogenization and extraction of
the intended target protein for denaturation. Gel
composition should effectively separate proteins by
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size, with changes to concentration giving resolution
to the intended target by varying migration speed.
Subsequent transfer onto an immobilizing mem-
brane will allow the probing for one or more targets
with 1°Ab and 2°Ab, with emphasis upon Ab speci-
ficity and the ability to assess PT modifications. Vali-
dation of Ab should always be undertaken, using
both positive and negative controls to try to ensure
specificity. Within each study design and group com-
parisons, QC samples should be used allowing the
comparison of multiple gels. The method of detec-
tion will be ultimately be determined by the equip-
ment available. However, fluorescent antibodies
have a greater dynamic range and may be multi-
plexed for additional targets if desired. As sample
quantity may be scarce, the ability to strip and
re-probe membranes for additional targets is desir-
able; however, potential issues with regard to quan-
tification and potential signal reduction should be
considered carefully and where possible mitigated.
Finally, the quantification and analysis of band
intensity should be evaluated consistently through-
out with both single and multiple blots; as doing so
can produce reliable and accurate data.
Perspectives
Western blotting techniques are now considered
routine inclusions within the field of physiology and
are invaluable in providing mechanistic insight into
many regulatory processes. The present review aimed
to give a comprehensive insight into the multiple
aspects within the WB process, providing the reader
with enhanced expertise to critically evaluate and
troubleshoot all features to produce reliable and
reproducible blots.
Key words: Westen blot, physiology, SDS PAGE,
skeletal muscle.
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